Have a personal or library account? Click to login
Public Oncologic Serum biobank Cover
Open Access
|Oct 2014

References

  1. Gatenby R A Gillies R J Why do cancers have high aerobic glycolysis? Nat Rev Cancer 2004 4 11 891 899 10.1038/ncr1478
  2. Ferrara N Gerber H P The role of vascular endothelial growth factor in angiogenesis Acta Haematol 2001 106 4 148 156 10.1159/000046610
  3. Wood C G Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy J Surg Oncol 2006 94 4 264 265
  4. Arsanious A Bjarnason G A Yousef G M From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma Mol Cancer 2009 8 20 10.1186/1476-4598-8-205
  5. Kim J J Vaziri S A Rini B I Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib Cancer 2011 10.1002/cncr.26491
  6. Li M Rathmell W The Current Status of Biomarkers for Renal Cell Carcinoma American Society of Clinical Oncology 2011 1 153 157
  7. Youssef Y M White N M Grigull J Accurate molecular classification of kidney cancer subtypes using microRNA signature Eur Urol 2011 59 5 721 730 10.1016/j.eururo.2011-01.004
  8. Perroud RB Lee J Valkova N Pathway analysis of kidney cancer using proteomics and metabolic profiling Mol Cancer 2006 5 64 10.1186/1476-4598-5-64
DOI: https://doi.org/10.5334/ojb.ae | Journal eISSN: 2056-5542
Language: English
Published on: Oct 7, 2014
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2014 Pedro Rondot Radío, Lydia Puricelli, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 3.0 License.